Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Neoplasm

Recruiting

Registered drugNo placebo

Study of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:ALE.P02

Contact Research Centre

Neoplasm+1

Recruiting

InvestigationalNo placebo

Study on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:VERT-002

Contact Research Centre

Neoplasm+7

Recruiting

Registered drugNo placebo

Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Neoplasm+2

Recruiting

InvestigationalNo placebo

Study on APL-101 for Treating Advanced Solid Tumors and Non-Small Cell Lung Cancer with MET Changes in Patients

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Apl-101

Contact Research Centre

Neoplasm+2

Recruiting

Registered drugNo placebo

Study Comparing ANV419 and High Dose IL2 in Adoptive Cell Therapy for Patients with Melanoma, Non-Small Cell Lung Cancer, and Cervical Cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Aldesleukin

Contact Research Centre

Neoplasm

Recruiting

Registered drugNo placebo

Study of IMP1734, Paclitaxel, and Abiraterone for Patients with Advanced Solid Tumors

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Abiraterone

Contact Research Centre

Neoplasm

Recruiting

Registered drugNo placebo

Study for Children and Adolescents with Recurrent or Relapsed Solid Tumors Using Lutetium (177Lu) Oxodotreotide and Olaparib

Registered drugNo placebo

Spain

Participants:0–17 years
Substances:Olaparib

Contact Research Centre

Neoplasm+1

Recruiting

Registered drugNo placebo

Study on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Binimetinib

Contact Research Centre

Neoplasm

Recruiting

Registered drugNo placebo

Study on Treating Solid Tumors with Genetically Modified T-Cells (IMA203, IMA203CD8) and Nivolumab for Patients with Recurrent or Refractory Conditions

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ima203Cd8

Contact Research Centre

Neoplasm

Recruiting

Registered drugNo placebo

Study of Drug Combination Treatment Based on Tumor Molecular Changes in Patients with Advanced or Metastatic Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cabozantinib

Contact Research Centre

Neoplasm

Recruiting

InvestigationalNo placebo

Study of ORIC-114 Alone or with Chemotherapy for Patients with Advanced Solid Tumors with EGFR or HER2 Alterations

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Oric-114

Contact Research Centre

Neoplasm+3

Recruiting

InvestigationalNo placebo

Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Cedazuridine

Contact Research Centre

Find therapies in clinical trials near you – page 3

158 trials match your criteria

Neoplasm

Study of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors

Neoplasm+1

Study on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations

Neoplasm+7

Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

Neoplasm+2

Study on APL-101 for Treating Advanced Solid Tumors and Non-Small Cell Lung Cancer with MET Changes in Patients

Neoplasm+2

Study Comparing ANV419 and High Dose IL2 in Adoptive Cell Therapy for Patients with Melanoma, Non-Small Cell Lung Cancer, and Cervical Cancer

Neoplasm

Study of IMP1734, Paclitaxel, and Abiraterone for Patients with Advanced Solid Tumors

Neoplasm

Study for Children and Adolescents with Recurrent or Relapsed Solid Tumors Using Lutetium (177Lu) Oxodotreotide and Olaparib

Neoplasm+1

Study on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors

Neoplasm

Study on Treating Solid Tumors with Genetically Modified T-Cells (IMA203, IMA203CD8) and Nivolumab for Patients with Recurrent or Refractory Conditions

Neoplasm

Study of Drug Combination Treatment Based on Tumor Molecular Changes in Patients with Advanced or Metastatic Cancer

Neoplasm

Study of ORIC-114 Alone or with Chemotherapy for Patients with Advanced Solid Tumors with EGFR or HER2 Alterations

Neoplasm+3

Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.